Analyst Ratings for Viridian Therapeutic (VRDN)
VRDN Rating Summary
VRDN Price Target Summary
- Highest: $61.00 (BTIG)
- Lowest: $22.00 (H.C. Wainwright)
- Average: $36.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$36.80 (+104.1%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
Rating Score: 8.9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/29/2026 | Wells Fargo | Derek Archila | Upgrade | Overweight (Equal Weight) |
31.00 (N/A) |
17.90 (18.03) |
0.73% | Details |
| 1/7/2026 | UBS » Updated 6/29/2026 |
Michael Yee | New Coverage | Buy (N/A) |
50.00 (50.00) |
30.20 (18.03) |
-40.3% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
